Get the Stockscreener App
0.00
100.00%
-4.58
Neurometrix Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical device.
See More
Previous Close:
$4.58
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$8.94M
Revenue:
$5.27M
Net Income/Loss:
$-7.98M
P/E Ratio:
0.00
EPS:
-5.9517
Net Cash Flow:
$-7.04M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$4.73
Neurometrix Inc Stock (NURO) Company Profile
Name
Neurometrix Inc
Sector
Industry
Phone
(781) 890-9989
Address
1000 WINTER STREET, WALTHAM
Compare NURO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
0.00 | 8.94M | 5.27M | -7.98M | -7.04M | -5.9517 |
|
ABT
Abbott Laboratories
|
135.20 | 224.53B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.54 | 152.31B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
389.55 | 148.10B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.37 | 109.16B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
77.83 | 44.29B | 5.54B | 4.18B | 623.10M | 7.00 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-17 | Reiterated | H.C. Wainwright | Buy |
| Jun-28-16 | Initiated | Rodman & Renshaw | Buy |
| Sep-11-15 | Initiated | Maxim Group | Buy |
| Feb-27-12 | Initiated | Dawson James | Buy |
Neurometrix Inc Stock (NURO) Latest News
NeuroMetrix Releases Q2 Results - Medical Product Outsourcing
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Tactile Systems Technology (NASDAQ:TCMD) vs. NeuroMetrix (NASDAQ:NURO) Financial Comparison - Defense World
Investor Network: NeuroMetrix, Inc. to Host Earnings Call - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
Renaissance Technologies LLC Purchases New Shares in NeuroMetrix, Inc. (NASDAQ:NURO) - Defense World
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
NeuroMetrix (NASDAQ:NURO) and Daxor (NASDAQ:DXR) Head-To-Head Comparison - Defense World
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
ElectroCore completes acquisition of NeuroMetrix - MassDevice
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
NeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at StockNews.com - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Survey - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix, Inc. SEC 10-K Report - TradingView
NeuroMetrix (NASDAQ:NURO) Stock Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
NeuroMetrix shareholders approve merger with electroCore By Investing.com - Investing.com Australia
NeuroMetrix shareholders approve merger with electroCore - Investing.com
Diabetic Neuropathic Pain Analysis Report 2025: Global - GlobeNewswire
NeuroMetrix (NASDAQ:NURO) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
electroCore Inc (ECOR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
NeuroMetrix, Inc. to Host Earnings Call - ACCESS Newswire
ElectroCore expands reach with Amazon listing for Truvaga Plus - Investing.com
Neurometrix Inc Stock (NURO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):